![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.3277 | 10.8509933775 | 3.02 | 3.45 | 2.94 | 1480613 | 3.10149725 | CS |
4 | 1.0077 | 43.0641025641 | 2.34 | 3.45 | 2.1 | 2651850 | 2.81647839 | CS |
12 | 1.1277 | 50.7972972973 | 2.22 | 3.45 | 1.81 | 2531255 | 2.47763747 | CS |
26 | 1.6277 | 94.6337209302 | 1.72 | 3.45 | 1.64 | 1565493 | 2.38026179 | CS |
52 | 0.8277 | 32.8452380952 | 2.52 | 3.45 | 1.51 | 1216223 | 2.27871605 | CS |
156 | -15.8523 | -82.5640625 | 19.2 | 24.47 | 1.51 | 851675 | 5.07799259 | CS |
260 | -12.5523 | -78.9452830189 | 15.9 | 24.47 | 1.51 | 855173 | 5.23795549 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions